Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Stoeck

Showing results (11-20 of 24) with videos related to

Pageof 3
Sort By:
BMC Anesthesiology|April 1, 2019
A comparison of blind intubation with the intubating laryngeal mask FASTRACH™ and the intubating laryngeal mask Ambu Aura-i™ a prospective randomised clinical trialR Schiewe, M Stoeck, M Gruenewald, et al.
Journal of Cellular Physiology|March 1, 1989
Comparison of phorbol-12-myristate-13-acetate and dioctanoyl-sn-glycerol in the activation of EL4/6.1 thymoma cellsM Stoeck, R Lees, M Szamel, et al.
FEBS Letters|June 5, 1989
Transforming growth factors beta 1 and beta 2 as well as milk growth factor decrease anti-CD3-induced proliferation of human lymphocytes without inhibiting the anti-CD3-mediated increase of [Ca2+]i and the activation of protein kinase CM Stoeck, H Sommermeyer, S Miescher, et al.
Clinical and Experimental Immunology|January 1, 1990
Stimulation of FACS-analysed CD4+ and CD8+ human tumour-infiltrating lymphocytes with ionomycin + phorbol-12,13-dibutyrate does not overcome their proliferative deficitM Stoeck, S Miescher, L Qiao, et al.
Cancer Research|December 15, 1988
Preferential clonogenic deficit of CD8-positive T-lymphocytes infiltrating human solid tumorsS Miescher, M Stoeck, L Qiao, et al.
Lymphokine and Cytokine Research|June 1, 1994
Activation of the mouse IL-2 gene by okadaic acid: synergy with interleukin-1W Falk, K Stricker, G Praast, et al.
International Journal of Cancer|November 15, 1988
Proliferative and cytolytic potentials of purified human tumor-infiltrating T lymphocytes. Impaired response to mitogen-driven stimulation despite T-cell receptor expressionS Miescher, M Stoeck, L Qiao, et al.
Immunobiology|August 1, 1990
Effect of transforming growth factor beta on the EL4 thymoma variant EL4/6.1: dissociation of inhibition of proliferation from expression of IL-1 and IL-2 receptorsM Stoeck, R C Howe, S Miescher, et al.
Journal of Cellular Physiology|June 1, 1995
Matrix protein synthesis by glomerular mesangial cells in culture: effects of transforming growth factor beta (TGF beta) and platelet-derived growth factor (PDGF) on fibronectin and collagen type IV mRNAG M Hänsch, C Wagner, A Bürger, et al.
Journal of Immunology (Baltimore, Md. : 1950)|November 15, 1989
Comparison of the immunosuppressive properties of milk growth factor and transforming growth factors beta 1 and beta 2M Stoeck, C Ruegg, S Miescher, et al.
Pageof 3

Showing results (11-20 of 24) with videos related to

Sort By:
Pageof 3
BMC Anesthesiology|April 1, 2019
A comparison of blind intubation with the intubating laryngeal mask FASTRACH™ and the intubating laryngeal mask Ambu Aura-i™ a prospective randomised clinical trialR Schiewe, M Stoeck, M Gruenewald, et al.
Journal of Cellular Physiology|March 1, 1989
Comparison of phorbol-12-myristate-13-acetate and dioctanoyl-sn-glycerol in the activation of EL4/6.1 thymoma cellsM Stoeck, R Lees, M Szamel, et al.
FEBS Letters|June 5, 1989
Transforming growth factors beta 1 and beta 2 as well as milk growth factor decrease anti-CD3-induced proliferation of human lymphocytes without inhibiting the anti-CD3-mediated increase of [Ca2+]i and the activation of protein kinase CM Stoeck, H Sommermeyer, S Miescher, et al.
Clinical and Experimental Immunology|January 1, 1990
Stimulation of FACS-analysed CD4+ and CD8+ human tumour-infiltrating lymphocytes with ionomycin + phorbol-12,13-dibutyrate does not overcome their proliferative deficitM Stoeck, S Miescher, L Qiao, et al.
Cancer Research|December 15, 1988
Preferential clonogenic deficit of CD8-positive T-lymphocytes infiltrating human solid tumorsS Miescher, M Stoeck, L Qiao, et al.
Lymphokine and Cytokine Research|June 1, 1994
Activation of the mouse IL-2 gene by okadaic acid: synergy with interleukin-1W Falk, K Stricker, G Praast, et al.
International Journal of Cancer|November 15, 1988
Proliferative and cytolytic potentials of purified human tumor-infiltrating T lymphocytes. Impaired response to mitogen-driven stimulation despite T-cell receptor expressionS Miescher, M Stoeck, L Qiao, et al.
Immunobiology|August 1, 1990
Effect of transforming growth factor beta on the EL4 thymoma variant EL4/6.1: dissociation of inhibition of proliferation from expression of IL-1 and IL-2 receptorsM Stoeck, R C Howe, S Miescher, et al.
Journal of Cellular Physiology|June 1, 1995
Matrix protein synthesis by glomerular mesangial cells in culture: effects of transforming growth factor beta (TGF beta) and platelet-derived growth factor (PDGF) on fibronectin and collagen type IV mRNAG M Hänsch, C Wagner, A Bürger, et al.
Journal of Immunology (Baltimore, Md. : 1950)|November 15, 1989
Comparison of the immunosuppressive properties of milk growth factor and transforming growth factors beta 1 and beta 2M Stoeck, C Ruegg, S Miescher, et al.
Pageof 3